期刊论文详细信息
Frontiers in Oncology
The Circ_0001367/miR-545-3p/LUZP1 Axis Regulates Cell Proliferation, Migration and Invasion in Glioma Cells
Yuan Wang1  Chaonan Zheng1  Li Zhang1  Peng Zhang2  Shan Cheng3  Suwen Li3  Haoran Li3  Jun Dong3  Liang Liu3  Xuchen Dong4 
[1] College of Pharmaceutical Sciences, Soochow University, Suzhou, China;Department of Neurosurgery, Rugao Hospital Affiliated to Nantong University, Nantong, China;Department of Neurosurgery, Second Affiliated Hospital of Soochow University, Suzhou, China;Medical College of Soochow University, Suzhou, China;
关键词: circRNA;    hsa_circ_0001367;    miR-545-3p;    LUZP1;    glioma;   
DOI  :  10.3389/fonc.2021.781471
来源: DOAJ
【 摘 要 】

Glioma is the most common primary intracranial malignant tumour in adults. It has a high incidence and poses a serious threat to human health. Circular RNA is a hotspot of cancer research. In this study, we aimed to explore the role of circ_0001367 in gliomagenesis and the underlying mechanism. First, qRT-PCR was conducted, which showed that circ_0001367 level was downregulated in glioma tissues and cells. Next, gain-of-function and loss-of-function assays were performed, which indicated that circ_0001367 inhibited the proliferation, migration and invasion of glioma cells. Subsequent bioinformatics analysis, dual-luciferase reporter assays, RNA immunoprecipitation assays and cell function assays demonstrated that circ_0001367 inhibited the proliferation, migration and invasion of glioma cells by absorbing miR-545-3p and thereby regulating the expression of leucine zipper protein (LUZP1). Finally, an in vivo experiment was conducted, which demonstrated that circ_0001367 inhibited glioma growth in vivo by modulating miR-545-3p and LUZP1. Taken together, the results of this study demonstrate that the circ_0001367/miR-545-3p/LUZP1 axis may be a novel target for glioma therapy.

【 授权许可】

Unknown   

  文献评价指标  
  下载次数:0次 浏览次数:1次